Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T17:32:43.592Z.
Calculation as of: 2026-10-06T17:32:43.592Z.
Quote observation: 2026-10-06T17:27:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0dc40ddd6b0c815ea8fb06d6c0f10798674f4babd9a38c246e46e89e51900236
PEG RATIO
N/A
Lite Strategy, Inc.
Market Cap
$48.32M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Lite Strategy, Inc. (LITS) | $48.32M | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.27M | N/A |
| TELA Bio, Inc. (TELA)vs › | $49.21M | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.45M | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | N/A |
| Apollomics, Inc. (APLM)vs › | $49.32M | N/A |
| Microbot Medical Inc. (MBOT)vs › | $49.34M | N/A |
| Celularity Inc. (CELU)vs › | $49.79M | N/A |
| Instil Bio, Inc. (TIL)vs › | $46.25M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.45M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
